The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial

In pediatric hematopoietic cell transplant (HCT) recipients, 2 doses of high-dose trivalent influenza vaccine were more immunogenic than 2 doses of standard-dos

Read the full article here

Related Articles